# The Branded Health Service Medicines (Costs) Regulations 2018, Regulation 29: Annual review


(1) Before the end of the review period, the Secretary of State must—
(a) carry out a review of these Regulations;
(b) set out the conclusions of the review in a report; and
(c) publish the report.
(2) The report must in particular—
(a) set out the objectives intended to be achieved by the scheme established by these Regulations;
(b) assess the extent to which these objectives are achieved; and
(c) assess whether those objectives remain appropriate and, if so, the extent to which they could be achieved with a system that imposes less regulation.
(3) Under this regulation, “review period” means the period of one year beginning on the date of the coming into force of these Regulations.

---
Source: https://www.legislation.gov.uk/uksi/2018/345/regulation/29 (the official version)
Page: https://openlegislation.uk/branded-health-service-medicines-costs-regulations-2018/regulation-29
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.